The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cell and Gene Therapy Core

As of first of January 2022, StemTherapy and MultiPark have decided to merge the former iPSC, CRISPR and vector platforms into the new Cell and Gene Therapy Core

The Cell and Gene Therapy core is an open-access infrastructure and our services include AAV and LV vector production, iPS reprogramming, iPS-edits and CRISPR experimental designs. The core is open to members of MultiPark as well as the SCC, and national and international users.

Go to the Cell and Gene Therapy Core website.

Core logotype